137 related articles for article (PubMed ID: 7990111)
1. Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Myers AM; Charifson PS; Owens CE; Kula NS; McPhail AT; Baldessarini RJ; Booth RG; Wyrick SD
J Med Chem; 1994 Nov; 37(24):4109-17. PubMed ID: 7990111
[TBL] [Abstract][Full Text] [Related]
2. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
Wyrick SD; Booth RG; Myers AM; Owens CE; Bucholtz EC; Hooper PC; Kula NS; Baldessarini RJ; Mailman RB
J Med Chem; 1995 Sep; 38(19):3857-64. PubMed ID: 7562917
[TBL] [Abstract][Full Text] [Related]
3. New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies.
Booth RG; Wyrick SD; Baldessarini RJ; Kula NS; Myers AM; Mailman RB
Mol Pharmacol; 1993 Dec; 44(6):1232-9. PubMed ID: 8264560
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Bucholtz EC; Brown RL; Tropsha A; Booth RG; Wyrick SD
J Med Chem; 1999 Aug; 42(16):3041-54. PubMed ID: 10447948
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.
Wyrick SD; Booth RG; Myers AM; Owens CE; Kula NS; Baldessarini RJ; McPhail AT; Mailman RB
J Med Chem; 1993 Aug; 36(17):2542-51. PubMed ID: 8102651
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations.
Gund TM; Floyd J; Jung D
J Mol Graph Model; 2004 Jan; 22(3):221-30. PubMed ID: 14629980
[TBL] [Abstract][Full Text] [Related]
7. Putative sigma(3) sites in mammalian brain have histamine H(1) receptor properties: evidence from ligand binding and distribution studies with the novel H(1) radioligand [(3)H]-(-)-trans-1-phenyl-3-aminotetralin.
Booth RG; Owens CE; Brown RL; Bucholtz EC; Lawler CP; Wyrick SD
Brain Res; 1999 Aug; 837(1-2):95-105. PubMed ID: 10433992
[TBL] [Abstract][Full Text] [Related]
8. A structure-affinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands.
Abate C; Mosier PD; Berardi F; Glennon RA
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):246-57. PubMed ID: 20021358
[TBL] [Abstract][Full Text] [Related]
9. A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain.
Choksi NY; Nix WB; Wyrick SD; Booth RG
Brain Res; 2000 Jan; 852(1):151-60. PubMed ID: 10661506
[TBL] [Abstract][Full Text] [Related]
10. Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.
Banister SD; Moussa IA; Jordan MJ; Coster MJ; Kassiou M
Bioorg Med Chem Lett; 2010 Jan; 20(1):145-8. PubMed ID: 19954972
[TBL] [Abstract][Full Text] [Related]
11. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands.
Jung D; Floyd J; Gund TM
J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333
[TBL] [Abstract][Full Text] [Related]
12. Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor.
Efange SM; Mach RH; Smith CR; Khare AB; Foulon C; Akella SK; Childers SR; Parsons SM
Biochem Pharmacol; 1995 Mar; 49(6):791-7. PubMed ID: 7702637
[TBL] [Abstract][Full Text] [Related]
13. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
14. A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
Banister SD; Manoli M; Doddareddy MR; Hibbs DE; Kassiou M
Bioorg Med Chem Lett; 2012 Oct; 22(19):6053-8. PubMed ID: 22959245
[TBL] [Abstract][Full Text] [Related]
15. 5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
Oberdorf C; Schmidt TJ; Wünsch B
Eur J Med Chem; 2010 Jul; 45(7):3116-24. PubMed ID: 20427100
[TBL] [Abstract][Full Text] [Related]
16. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and receptor affinity of novel conformationally restricted σ ligands based on the [4.3.3]propellane scaffold.
Torres-Gómez H; Lehmkuhl K; Schepmann D; Wünsch B
Eur J Med Chem; 2013; 70():78-87. PubMed ID: 24140950
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
Zampieri D; Mamolo MG; Laurini E; Florio C; Zanette C; Fermeglia M; Posocco P; Paneni MS; Pricl S; Vio L
J Med Chem; 2009 Sep; 52(17):5380-93. PubMed ID: 19673530
[TBL] [Abstract][Full Text] [Related]
19. GRIND-derived pharmacophore model for a series of alpha-tropanyl derivative ligands of the sigma-2 receptor.
Cratteri P; Romanelli MN; Cruciani G; Bonaccini C; Melani F
J Comput Aided Mol Des; 2004 May; 18(5):361-74. PubMed ID: 15595462
[TBL] [Abstract][Full Text] [Related]
20. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
